For the first time at the state level, health care providers from around Oregon are gathering at a single forum to learn about the newest cutting-edge treatments for patients who suffer cardiac arrest. The Oregon Cardiac Arrest Management Symposium will feature presentations on topics such as new drug treatments, defibrillators, hypothermia therapy and research into genes that may identify people at highest risk for cardiac arrest.

Reporters are invited to hear about the latest developments in cardiac arrest management from researchers, physicians and emergency medical technicians who are experts in the field.

The symposium will be at the Benson Hotel in Portland from 8 a.m. to 4:40 p.m. on Friday, March 5. The program is being coordinated by Sumeet Chugh, M.D., associate professor of medicine (cardiology) in the OHSU School of Medicine and director of the Heart Rhythm Research Laboratory at OHSU, and Jonathan Jui, M.D., professor of emergency medicine in the OHSU School of Medicine.

Presentation titles include:

• Amiodarone Before Lidocaine: A Twist in the Tale of Antiarrhythmic Drugs
• Vasopressin: Pressor with Promise?
• Why Defibrillation Works: Monophasic, Biphasic and Future Shocks
• Utility of AEDs: What Have We Learned from the Public Access Defibrillation Study
• The 3,000-Year Quest to Reverse Sudden Death
• 12-Lead and Enzymes in the Field: Should We Go For It?
• Hypothermia: Cool Therapy, But Is It Ready for Prime Time?
• Managing the Survivor: Implantable Defibrillators and Immortality
• Cardiac Arrest and the Human Genome: Unlocking the Secrets of Biology's Storehouse

There will be several panel discussions with leading experts in this field between presentations.

For a comprehensive schedule of the program, please visit www.ohsu.edu/ohsu-cme or www.oregonsuds.org.

###